To meet the EB-2 NIW standard, the legal team focused the petition on the client’s broader contribution to U.S.
In early 2026, antimicrobial resistance remains a growing concern for U.S. public health agencies and hospital systems.
EB Research Partnership ("EBRP") invested in the work that led to ZEVASKYN at Stanford University under their pioneering Venture Philanthropy Model. This approval marks a historic moment for the EB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results